What is OS Therapies's common stock, shares, outstanding?

OS Therapies (OSTX) reported common stock, shares, outstanding of $39.28M in Q1 2026.

How has OS Therapies's common stock, shares, outstanding changed year-over-year?

OS Therapies's common stock, shares, outstanding increased by 84.0% year-over-year, from $21.35M to $39.28M.

What is the long-term trend for OS Therapies's common stock, shares, outstanding?

Over 2 years (2023 to 2025), OS Therapies's common stock, shares, outstanding has grown at a 163.6% compound annual growth rate (CAGR), from $5.34M to $37.11M.

OS Therapies OSTX Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

CTO

Citius Oncology, Inc.CTOR

——

Avalo TherapeuticsAVTX

——

Arcus BiosciencesRCUS

——

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's common stock, shares, outstanding?: OS Therapies (OSTX) reported common stock, shares, outstanding of $39.28M in Q1 2026.
How has OS Therapies's common stock, shares, outstanding changed year-over-year?: OS Therapies's common stock, shares, outstanding increased by 84.0% year-over-year, from $21.35M to $39.28M.
What is the long-term trend for OS Therapies's common stock, shares, outstanding?: Over 2 years (2023 to 2025), OS Therapies's common stock, shares, outstanding has grown at a 163.6% compound annual growth rate (CAGR), from $5.34M to $37.11M.